These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20488516)

  • 1. The HIV-associated tuberculosis epidemic--when will we act?
    Harries AD; Zachariah R; Corbett EL; Lawn SD; Santos-Filho ET; Chimzizi R; Harrington M; Maher D; Williams BG; De Cock KM
    Lancet; 2010 May; 375(9729):1906-19. PubMed ID: 20488516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.
    Hakim J; Musiime V; Szubert AJ; Mallewa J; Siika A; Agutu C; Walker S; Pett SL; Bwakura-Dangarembizi M; Lugemwa A; Kaunda S; Karoney M; Musoro G; Kabahenda S; Nathoo K; Maitland K; Griffiths A; Thomason MJ; Kityo C; Mugyenyi P; Prendergast AJ; Walker AS; Gibb DM;
    N Engl J Med; 2017 Jul; 377(3):233-245. PubMed ID: 28723333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulation.
    Harries AD; Lawn SD; Suthar AB; Granich R
    Lancet Infect Dis; 2015 Dec; 15(12):1492-6. PubMed ID: 26515525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.
    Lawn SD; Harries AD; Meintjes G; Getahun H; Havlir DV; Wood R
    AIDS; 2012 Nov; 26(17):2121-33. PubMed ID: 22695302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment.
    Dierberg KL; Chaisson RE
    Clin Chest Med; 2013 Jun; 34(2):217-28. PubMed ID: 23702172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV.
    Date AA; Vitoria M; Granich R; Banda M; Fox MY; Gilks C
    Bull World Health Organ; 2010 Apr; 88(4):253-9. PubMed ID: 20431788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.
    Rangaka MX; Wilkinson RJ; Boulle A; Glynn JR; Fielding K; van Cutsem G; Wilkinson KA; Goliath R; Mathee S; Goemaere E; Maartens G
    Lancet; 2014 Aug; 384(9944):682-90. PubMed ID: 24835842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing opportunistic infections among human immunodeficiency virus-infected adults in African countries.
    Grant AD; Kaplan JE; De Cock KM
    Am J Trop Med Hyg; 2001 Dec; 65(6):810-21. PubMed ID: 11791979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
    Habib AG
    Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children.
    Gray DM; Zar H; Cotton M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006418. PubMed ID: 19160285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
    Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries.
    Charles MK; Lindegren ML; Wester CW; Blevins M; Sterling TR; Dung NT; Dusingize JC; Avit-Edi D; Durier N; Castelnuovo B; Nakigozi G; Cortes CP; Ballif M; Fenner L;
    PLoS One; 2016; 11(4):e0153243. PubMed ID: 27073928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis.
    Okwera A; Mafigiri DK; Guwatudde D; Whalen C; Joloba M
    Afr Health Sci; 2015 Mar; 15(1):49-57. PubMed ID: 25834530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New vaccines for the prevention of tuberculosis in human immunodeficiency virus infection.
    von Reyn CF; Bakari M; Arbeit RD; Lahey T; Ramadhani A; Egwaga S
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):718-23. PubMed ID: 22507085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult tuberculosis overview: African versus Western perspectives.
    Johnson JL; Ellner JJ
    Curr Opin Pulm Med; 2000 May; 6(3):180-6. PubMed ID: 10782700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations.
    Cohen T; Lipsitch M; Walensky RP; Murray M
    Proc Natl Acad Sci U S A; 2006 May; 103(18):7042-7. PubMed ID: 16632605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive treatment for tuberculosis in people with HIV.
    Swaminathan S
    Lancet; 2014 Aug; 384(9944):644-6. PubMed ID: 24835843
    [No Abstract]   [Full Text] [Related]  

  • 18. Isoniazid prevented active tuberculosis in patients with HIV treated with antiretroviral therapy.
    Sacks HS
    Ann Intern Med; 2014 Sep; 161(6):JC12. PubMed ID: 25222412
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuberculosis preventive therapy in people living with HIV in sub-Saharan Africa.
    Godfrey-Faussett P
    AIDS; 1999 Aug; 13(12):1581-2. PubMed ID: 10465084
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.